A team of Canadian researchers at McMaster University is developing an inhalable TB vaccine that would act as a booster to strengthen immune protection right at the site of infection — the lungs. If successful, it would be among the first new effective TB vaccines in the world.
Organization: Ottawa Hospital
The Short Report – March 10, 2021: Federal funding for applied genomics, investments in plant-based proteins, the death of a renowned Alberta ecologist, and more
The Government of Canada invests $8.6 million towards applied genomics research with another $17.8 million from its partners, Protein Industries Canada funds three plant-based protein projects, the death of renowned Alberta ecologist Dr. David Schindler, and more.
BC Innovation Commissioner’s final report calls for regional precincts to boost economic performance
Reports says BC needs boosts its R&D spending by $2.5 billion through partnerships with the federal government, the private sector and international investors.
OLSC announces business case winners
The first business case competition of the Ottawa Life Sciences Council (OLSC) has produced five winners. Each winner will be paired with a local entrepreneur who will help develop an effective business plan. The winners with their respective mentors in brackets are: Andy Adler, Univ of Ottawa (Adam Chowaniec, Tundra Semiconductor Corp); May Griffith, Univ…
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...